A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BPI-21668
Clinical trial NCT05341570 · UNKNOWN
Trial details
- NCT number
- NCT05341570
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-19
- Primary completion
- 2024-01-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.